Trials / Completed
CompletedNCT01220063
RSHF in Colorectal Cancer
CLINICAL MULTICENTER STUDY OF PHASE II AND RADIOBIOLOGY ASSESSING Hypofractionated Stereotactic Radiotherapy With Irinotecan (Campto) IN THE TREATMENT OF LIVER METASTASIS AND / OR PULMONARY, Unoperated or Recurrent After Surgery of a Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Institut Cancerologie de l'Ouest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study stereotactic radiotherapy with a dose of 40 Gy in 4 fractions over 2 weeks with concomitant 40 mg/m2 of irinotecan (1st and 3rd irradiation session).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiation | 10 Gy for 4 times (total 40 Gy) |
| DRUG | Irinotecan | 40 mg/m² : Day 1 and day 8 |
Timeline
- Start date
- 2007-10-19
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2010-10-13
- Last updated
- 2019-01-07
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01220063. Inclusion in this directory is not an endorsement.